1992 - 1994: Mathematics course, FernUniversität Hagen, Hagen
1991 - 1992: Internship in Internal Medicine, Hematology-Oncology & AIDS Center, University of Cologne and University of Homburg/Saar, Homburg
1987 - 1990: Doctoral thesis, Clinic I of Internal Medicine, University of Cologne, Cologne (Supervisor Michael Pfreundschuh) Bispezifische monoklonale Antikörper zur Aktivierung von Zytostatikavorstufen an Tumorzellen
1984 - 1990: Medical studies, University of Cologne, Cologne
1999: Habilitation in Molecular Medicine and Immunology at the University of Homburg/Saar, Homburg
1992: Promotion (Summa cum laude)
2018 - present: Co-founder and Scientific Chair of Managing Board, Helmholtz Institute TRON (HI-TRON), Mainz
2017 - present: Deputy Chairman, University Cancer Center (UCT), Mainz
2012 - present: Co-founder, CI3 Cluster of Individualized Immune Intervention
2010 - 2019: Scientific Director, TRON gGmbH
2010 - present: Co-founder, TRON gGmbH
2009 - present: Founding CEO, BioNTech AG, Mainz
2006 - 2013: W2 Associate Professor, Division of Experimental and Translational Oncology, University Medical Center, Johannes Gutenberg University, Mainz
2003 - 2015: Head, Tumor Vaccine Center, III. Dept. of Internal Medicine, Hematology and Oncology, University Medical Center, Johannes Gutenberg University, Mainz
2001: Co-founder, Ganymed Pharmaceuticals AG, Mainz
2001 - 2008: Junior Research Group Leader, Collaborative Research Center SFB 432, University Medical Center, Johannes Gutenberg University, Mainz
2000 - 2001: Visiting Scientist, Department for Experimental Immunology, University Hospital Zurich, Zurich, Switzerland (Rolf Zinkernagel & Hans Hengartner)
1992 - 2000: Resident in Internal Medicine, Dept. Hematology-Oncology at the University of Homburg/Saar, Homburg
2019: Deutscher Krebspreis 2019
2018: 2017 ERC Advanced Grant in Life Sciences
2015 - present: American Society of Clinical Oncology (ASCO)
2014 - present: American Association for Cancer Research (AACR)
2012: BMBF Spitzencluster Award for TRON projects as part of CI3-Regional Cluster for Individualized Immune Intervention
2012 - 2017: Co-founder, CI3 Cluster of Individualized Immunointervention
201:1 STEP Award
2008 - present: Program Committee, Association for Cancer Immunotherapy (CIMT) Regulatory Research Group, Mainz, Germany
2006 & 2010: GoBio Award of the German Ministry of Education and Research (BMBF)
2005: Georges Köhler-Prize of the German Association of Immunology
2004 - present: German Society for Immunology (DGfI)
1997: Calogero-Paglierello-Research-Award
1995: Merit Award of the American Society of Oncology (ASCO)
1995: Vincenz Czerny Prize of the German Association of Hemato-Oncology (DGHO)
Professor (W3), Co-Founder TRON, Co-Founder & CEO BioNTech
Johannes Gutenberg University Mainz
Division of Experimental and Translational Oncology, University Medical Center